Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Indumathy Varadarajan"'
Autor:
Indumathy Varadarajan, Karen Ballen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
T-cell prolymphocytic leukemia (T-PLL) is a rare, aggressive hematologic malignancy with a poor prognosis. Alemtuzumab (Campath) remains the cornerstone for treatment, with an 80% complete response (CR). Hematopoietic stem cell transplant (HSCT) is c
Externí odkaz:
https://doaj.org/article/222afd0b44024845b93112980783e446
Autor:
Indumathy Varadarajan, Aparna Basu, Sherri Besmer, Jaganmohan Poli, Scott Richard, Michael Styler
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 2, Pp 694-698 (2017)
Cervical cancer is the fourth most common cancer in women worldwide, with a large majority of prevalence (85%) in developing countries. As of 2012, it accounts for 7.5% of all female cancer deaths. Despite its high prevalence, skeletal muscle metasta
Externí odkaz:
https://doaj.org/article/3e1722b517444ee2bdd39158ed4272da
Publikováno v:
OncoTargets and Therapy. 16:1-16
Autor:
Nicholas P Lucchesi, Philip Young, Ravdeep Mathone, Leonid Volodin, Karen K Ballen, Indumathy Varadarajan
Publikováno v:
Transplantation and Cellular Therapy. 29:S143
Autor:
Indumathy Varadarajan, Bethany Horton, Leonid Volodin, Tamila Kindwall-Keller, Karen K Ballen
Publikováno v:
Transplantation and Cellular Therapy. 28:S158-S159
Autor:
Indumathy Varadarajan, Shambhavi Singh, Ioannis Vassalos, Leonid Volodin, Tamila Kindwall-Keller, Karen K Ballen
Publikováno v:
Transplantation and Cellular Therapy. 28:S269-S270
Autor:
Daniel R. Reed, Gina R. Petroni, Melissa West, Caroline Jones, Abeer Alfaraj, Paige G. Williams, Kathlene DeGregory, Kyle Grose, Sandra Monson, Indumathy Varadarajan, Leonid Volodin, Gerald R. Donowitz, Tamila L. Kindwall-Keller, Karen K. Ballen
Publikováno v:
Hematology/Oncology and Stem Cell Therapy.
Cytomegalovirus (CMV) reactivation remains a serious complication after allogeneic hematopoietic cell transplantation (HCT) occurring in approximately 60-70% of CMV-seropositive HCT recipients. CMV reactivation leads to adverse outcomes including end
Autor:
Indumathy Varadarajan, Daniel W. Lee
Publikováno v:
The Cancer Journal. 25:223-230
The advent of T-cell-mediated immunotherapy has led to a new era in the treatment of relapsed, refractory B-cell lymphomas and leukemias. Chimeric antigen receptor T-cell and engineered T-cell receptor therapies have demonstrated impressive efficacy
Cytokine release syndrome (CRS) is the most frequently occurring toxicity in patients treated with chimeric antigen receptor T-cell therapies. The definition and grading of CRS has varied over the years. Only recently has the community come to consen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::700eed2d3c117120e9f35a7bf8216bd1
https://doi.org/10.1016/b978-0-323-66181-2.00005-6
https://doi.org/10.1016/b978-0-323-66181-2.00005-6
Autor:
Nabil Ahmed, Jacob S. Appelbaum, Karen Ballen, Cathy Conry Cantilena, Francesco Ceppi, Kenneth Cornetta, Kevin J. Curran, Terry J. Fry, Rebecca A. Gardner, Juliane Gust, Cristina Gutierrez, Steven L. Highfill, Elad Jacoby, Ping Jin, Sujith K. Joseph, Tamila L. Kindwall-Keller, Krishna V. Komanduri, Daniel W. Lee, Kris M. Mahadeo, Eoghan Molloy, Victor M. Orellana-Noia, Rimas J. Orentas, Sandhya Ramanathan Panch, Jae H. Park, Karlo Perica, Navin Pinto, Craig A. Portell, Michael A. Pulsipher, Khaled Sanber, Nirali N. Shah, Haneen Shalabi, David Stroncek, Corinne Summers, Francesco Paolo Tambaro, Agne Taraseviciute, Cameron J. Turtle, Indumathy Varadarajan, Alan S. Wayne, Kamille A. West
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d17c50135c4a6dff1601fec7acd4f9b3
https://doi.org/10.1016/b978-0-323-66181-2.01002-7
https://doi.org/10.1016/b978-0-323-66181-2.01002-7